CATHERINE BITTINGER: Open Payments
NPI 1174004113 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,852 in 92 payments from 32 companies in 2025. Trend: 2023 $512 · 2024 $1,193 · 2025 $1,852
Food & beverage: $1,791Education: $61
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 15 | $266 |
| ABBVIE INC. | 10 | $223 |
| Novartis Pharmaceuticals Corporation | 7 | $168 |
| Merck Sharp & Dohme LLC | 4 | $99 |
| Genentech USA, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Eisai Inc. | 3 | $71 |
| Lilly USA, LLC | 3 | $64 |
| ARRAY BIOPHARMA INC | 10 | $59 |
Products named: EPKINLY, VENCLEXTA, KEYTRUDA, Nubeqa, BRAFTOVI, Lenvima, KISQALI, VERZENIO.
Industry payments across GA — which companies pay providers there.
